Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...

I've always been vigilant about monitoring my skin for unusual spots since I have a family history of melanoma in addition to ...

Tildrakizumab maintained efficacy and safety in obese patients with scalp psoriasis over 52 weeks. Find out more about the ...

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where ...

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the lab ...

Psoriasis is a chronic skin disease that affects more than 8 million people in the U.S.Caused by an overactive immune system, ...

Adults with psoriasis who received text messages with guidance on diet, exercise and other lifestyle strategies engaged in ...

Adults with moderate to severe psoriasis and overweight or obesity were more likely to achieve complete skin clearance plus ...

A cohort analysis finds that risankizumab shows the lowest risk for serious infections compared to other systemic therapies ...

Learn how to manage hereditary angioedema (HAE) attacks with on-demand medications, from identifying early symptoms to ...

Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...